Search Results

World Health Organization Sub-types, Initial Treatment Outcome and Prognostic Study of Unselected Adult Patients with Acute Myeloid Leukaemia in Shanghai: an Analysis of 623 Cases

Authors: Ma, Y.; Wang, X.; Xu, X.; Lin, G.

Source: The Journal of International Medical Research, Volume 37, Number 4, July 2009 , pp. 1191-1201(11)

Publisher: Field House Publishing

Facile synthesis of 1H, 4H-cyclopenta[c]pyrrolo[1,2-b]isoquinolin-2(3H)-one

Authors: Sun, Mo Ran; Lu, Hong Tao; Yang, Hua

Source: Journal of Chemical Research, Volume 2009, Number 4, April 2009 , pp. 255-257(3)

Publisher: Science Reviews 2000 Ltd

Homoharringtonine inhibits the AKT pathway and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

Authors: Meng, Haitao; Yang, Chunmei; Jin, Jie; Zhou, Yuhong; Qian, Wenbin

Source: Leukemia and Lymphoma, Volume 49, Number 10, October 2008 , pp. 1954-1962(9)

Publisher: Informa Healthcare

Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells

Authors: Tong, Hongyan; Ren, Yanling; Zhang, Fengjuan; Jin, Jie

Source: European Journal of Haematology, Volume 81, Number 4, October 2008 , pp. 259-266(8)

Publisher: Blackwell Publishing

Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype

Authors: Mi, Yingchang; Xue, Yanping; Yu, Wenjuan; Liu, Shihe; Zhao, Yaozhong; Meng, Qingxiang; Bian, Shougeng; Wang, Jianxiang

Source: Leukemia and Lymphoma, Volume 49, Number 3, March 2008 , pp. 524-530(7)

Publisher: Informa Healthcare

Homoharringtonine for the treatment of chronic myelogenous leukemia

Authors: Quintás-Cardama, Alfonso; Cortes, Jorge

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 6, April 2008 , pp. 1029-1037(9)

Publisher: Informa Healthcare

ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms

Authors: Kuroda, Junya; Kimura, Shinya; Andreeff, Michael; Ashihara, Eishi; Kamitsuji, Yuri; Yokota, Asumi; Kawata, Eri; Takeuchi, Miki; Tanaka, Ruriko; Murotani, Yoshihide; Matsumoto, Yosuke; Tanaka, Hideo; Strasser, Andreas; Taniwaki, Masafumi; Maekawa, Taira

Source: British Journal of Haematology, Volume 140, Number 2, January 2008 , pp. 181-190(10)

Publisher: Blackwell Publishing

Homoharringtonine induces apoptosis and growth arrest in human myeloma cells

Authors: Lou, Yin-Jun; Qian, Wen-Bin; Jin, Jie

Source: Leukemia and Lymphoma, Volume 48, Number 7, July 2007 , pp. 1400-1406(7)

Publisher: Informa Healthcare

Homoharringtonine-induced apoptosis of MDS cell line MUTZ-1 cells is mediated by the endoplasmic reticulum stress pathway

Authors: Jie, Hu; Donghua, He; Xingkui, Xue; Liang, Gao; Wenjun, Wu; Xiaoyan, Han; Zhen, Cai

Source: Leukemia and Lymphoma, Volume 48, Number 5, May 2007 , pp. 964-977(14)

Publisher: Informa Healthcare

Gene Expression Profiling in Apoptotic K562 Cells Treated by Homoharringtonine

Authors: JIN, Wei; WU, Jiong; ZHUANG, Zhigang; LI, Junjie; FEI, Fei; DI, Genhong; CHEN, Ying; YAO, Ming; SHAO, Zhimin

Source: Acta Biochimica et Biophysica Sinica, Volume 39, Number 12, December 2007 , pp. 982-991(10)

Publisher: Blackwell Publishing

Gene expression pattern in apoptotic QGY-7703 cells induced by homoharringtonine

Authors: JIN, Wei; QU, Le-feng; CHEN, Qin; CHANG, Xin-zhong; WU, Jiong; SHAO, Zhi-min

Source: Acta Pharmacologica Sinica, Volume 28, Number 6, June 2007 , pp. 859-868(10)

Publisher: Blackwell Publishing

Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development

Authors: Darwiche, Nadine; El-Banna, Sara; Gali-Muhtasib, Hala

Source: Expert Opinion on Drug Discovery, Volume 2, Number 3, March 2007 , pp. 361-379(19)

Publisher: Informa Healthcare

Homoharringtonine shows potential in the treatment of imatinib-resistant chronic myeloid leukaemia

Source: Inpharma, Volume 1, Number 1577, 2007-03-03 , pp. 5-5(1)

Publisher: Adis International

Targeted Therapies from `Down Under': ChemGenex Combating Chronic Diseases

Author: Adis International Limited,

Source: Pharmaceutical & Diagnostic Innovation, Volume 4, Number 2, 2006 , pp. 10-12(3)

Publisher: Adis International

Other US regulatory news

Source: Inpharma, Volume 1, Number 1530, 2006-03-25 , pp. 18-18(1)

Publisher: Adis International

Chronic Leukemias - Progress and Challenges

Author: Adis International Limited,

Source: Pharmaceutical & Diagnostic Innovation, Volume 3, Number 12, 2005 , pp. 11-13(3)

Publisher: Adis International

Development of a pre-purification process for homoharringtonine

Authors: Sung, Ju-Li; Kim, Byung-Sik; Kim, Jin-Hyun

Source: Journal of Chemical Technology & Biotechnology, Volume 80, Number 10, October 2005 , pp. 1148-1153(6)

Publisher: John Wiley & Sons, Ltd.

Homoharringtonine: A New Treatment Option for Myeloid Leukemia

Authors: Luo, Chang Ying; Tang, Jing Yan; Wang, Yao Ping

Source: Hematology, Volume 9, Number 4, August, 2004 , pp. 259-270(12)

Publisher: Maney Publishing

Treatment with imatinib mesylate following triple therapy with interferon-, cytarabine and homoharringtonine may improve prognosis in CML

Source: Inpharma, Volume 1, Number 1412, 2003 , pp. 19-19(1)

Publisher: Adis International

HPLC-Electrospray Ionization-MS-MS Analysis of Cephalotaxus harringtonia Leaves and Enhancement of the Extraction Efficiency of Alkaloids Therein by SFE

Authors: Choi Y.H.; Yoo K-P.; Kim J.

Source: Journal of Chromatographic Science, Volume 41, Number 2, February 2003 , pp. 67-72(6)

Publisher: Preston Publications